HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $21 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.1%

Neg 0% Neu 87.1% Pos 0%

HC Wainwright & Co. analyst Yi Chen reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $21 price target.